OP0154 BUTYRATE IMPROVING THE INTESTINAL BARRIER VIA PROMOTING THE PROLIFERATION OF INTESTINAL STEM CELLS AND THEREBY ALLEVIATES THE ADVANCEMENT OF RHEUMATOID ARTHRITIS

作者
Ran Wang,N. Wang,Xu Zhang,D. Lu,Jing He
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:84: 132-133
标识
DOI:10.1016/j.ard.2025.05.175
摘要

Background: The deterioration of gut-barrier integrity facilitates the onset of arthritis and suggests the restoration of gut-barrier homeostasis as a novel therapeutic strategy for RA. The self-renewal and differentiation of intestinal epithelial stem cells (ISCs) are crucial for maintaining the integrity and functionality of the intestinal barrier. Previous works suggestd that butyrate has a substantial preventative effect on RA by targeting osteoclasts as well as cellular and humoral immune responses. Additionally, butyrate serves as the primary energy source for colonic substance metabolism.The mechanism via which butyrate alleviates the advancement of RA by promoting the proliferation of ISCs thereby improving the intestinal barrier remains undisclosed. Objectives: To elucidate the mechanism that butyrate mitigates the progression of RA by enhancing the self-renewal and differentiation of colonic stem cells and reinstating the intestinal barrier. Methods: Constructed with male DBA/1 mice, the established collagen-induced arthritis (CIA) mice received butyrate (200 mg/kg/d, po) over a period of 4 weeks (n = 6) (Figure 1). The arthritis score was estimated bi-daily. The posterior ankles were harvested for hematoxylin and eosin (HE) staining and micro CT to evaluate the synovial inflammation and bone erosion. The spleen and the joint draining lymph nodes (DLNs) were collected for flow cytometric analysis to examine the alterations in immune cell subsets following butyrate therapy. Colon and small intestine tissues were gathered for immunofluorescence (IF) and HE staining. An investigation of the additional mechanism by which butyrate improves colon ISC function in RA was conducted using single-cell RNA sequencing (scRNA-seq). Results: Intragastric butyrate administration was initiated after two immunizations (Figure 4A). Compared to CIA model fed a normal chow diet, butyrate treatment reduced the arthritis score prominently (P = 0.001, Figure 4B). A downward trend in the severity of joint inflammation and bone erosion was observed (Figures 4C). Flow cytometry analysis of B cells revealed that butyrate administration reduced the proportion of CD4+CD220+CD95+ germinal center B (GCB) cells in the joint draining lymph nodes (DLNs) (Figure 4D). In T cells, butyrate administration reduced the proportion of CD4+CD8−CXCR5+PD-1+ T follicular helper (TFH) cells in both the DLNs (P < 0.001; Figure 5E) and the spleen (P < 0.05; Figure 4E). Furthermore, a significant increase in the proportion of CD4+CD25+Foxp3+ regulatory T cells (Tregs) was observed in both the DLNs (P < 0.001; Figure 5F) and the spleen (P < 0.001; Figure 4F). These results confirm the protective effects of intestinal butyrate in the development of rheumatoid arthritis (RA). In the CIA model, the crypt height of the intestine was decreased compared to the normal group, but butyrate supplements can restore the crypt height backup to normal levels (P < 0.0001, Figure. 2A and C). Although there is no difference in colon crypt height between CIA model and the control group, butyrate can enhance it (P < 0.05, Figure 2E). The scRNA-seq of colon tissue indicated that the proliferation of ISCs in the butyrate group was greater than CIA group (Figure 2B and D). GSVA analysis showed that the butyrate metabolism score of ISCs increased subsequent to the butyrate supplementation (P < 0.0001, Figure. 2F). As anticipated, following butyrate administration, ISCs have a distinct gene expression profile compared to those in the CIA paradigm (Figure 2H). The upregulated genes predominantly participate in the cellular stress response, particularly the heat shock protein family, which is crucial for cellular adaptation to oxidative stress, inflammation, and tissue repair. The enriched upgrading pathways were assessed using KEGG and GSEA, identifying Wnt signaling pathways and IL3 signaling pathways (Figure 2J to L) as the potential mechanisms by which butyrate facilitates the differentiation of ISCs. Conclusion: Butyrate can improving the intestinal barrier via promoting the proliferation of intestinal stem cells and thereby alleviates the advancement of rheumatoid arthritis. REFERENCES: NIL . Figure 1Butyrate suppresses immune responses and reduces joint inflammation and bone destruction in mice. (A) Scheme of the experimental design for a butyrate diet using the classic CIA mouse model of RA. (B) Arthritis scores in CIA mice with or without butyrate supplementation.(C) Arthritis and bone erosion of the posterior ankles by photos, micro-CT (middle) and hematoxylin and eosin (H&E)–stained (left) analysis (Zoom in 50 times).(D to H) Representative flow cytometry plots with graphs showing the frequency of B220+ CD4− CD95+ GL-7+ germinal center B cells (D), CD4+ CD25+ Foxp3+ Tregs (F and H), and CD4+ CXCR5+ PD1+ Bcl6+ TFH cells (E and G). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Figure 2Butyrate suppresses immune responses and reduces joint inflammation and bone destruction in mice. (A and B) Tissues from the small intestine and colon subjected to HE staining. (C and D) Graphs of crypt height of small intestine and colon. (E) Umap plot of intestinal epithelial cells (IECs) (left) beside a stacked histogram displaying the quantities of each type of IECs (right) classified by CIA and butyrate group. (F) GSVA analysis of butanoate metabolism pathway in intestinal stem cells. (G) The graph displays the mean fluorescence intensity (MFI) of MUC2 immunofluorescence. (H) Volcano plot depicting transcript fold change of ISCs before and after butyrate administration versus P value. (I) Bar plots showing the DEG (differential expressed genes) enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of ISCs exposed to butyrate administration. (J and K) GSEA plot. (C, D and G). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Acknowledgements: Thanks to all the participating researchers and the experimental animals. Disclosure of Interests: None declared . © The Authors 2025. This abstract is an open access article published in Annals of Rheumatic Diseases under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Neither EULAR nor the publisher make any representation as to the accuracy of the content. The authors are solely responsible for the content in their abstract including accuracy of the facts, statements, results, conclusion, citing resources etc.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
781473059完成签到,获得积分10
刚刚
Jimmy完成签到,获得积分10
刚刚
WANG01DU完成签到,获得积分10
1秒前
欧阳完成签到,获得积分10
1秒前
botao_li完成签到,获得积分10
1秒前
咩咩完成签到,获得积分10
1秒前
科研通AI6.2的应助被tszjw168采纳,获得10
2秒前
纳米酶催化完成签到,获得积分10
3秒前
yexing完成签到,获得积分10
3秒前
Kal完成签到 ,获得积分10
3秒前
清都山水郎完成签到,获得积分10
3秒前
4秒前
wen完成签到,获得积分10
4秒前
半点禅完成签到,获得积分10
4秒前
周辰完成签到,获得积分10
4秒前
79发布了新的文献求助10
4秒前
李健的小迷弟的应助被CO2采纳,获得10
5秒前
大盘菜完成签到,获得积分10
5秒前
Aaron完成签到 ,获得积分10
5秒前
刘亚军完成签到 ,获得积分10
6秒前
email完成签到,获得积分10
6秒前
MongMong完成签到,获得积分20
6秒前
二月完成签到,获得积分20
6秒前
还我小小嘴完成签到,获得积分10
7秒前
天真大碗完成签到,获得积分10
7秒前
聂大猛完成签到,获得积分10
7秒前
botao_li发布了新的文献求助10
7秒前
草莓大王完成签到,获得积分10
7秒前
乔治完成签到,获得积分10
8秒前
虹膜完成签到,获得积分10
8秒前
SS完成签到,获得积分10
8秒前
AAAA完成签到,获得积分10
8秒前
koreyosh完成签到 ,获得积分10
8秒前
草果完成签到,获得积分10
9秒前
shawnho完成签到,获得积分10
9秒前
MOMO完成签到,获得积分10
9秒前
思茶念酒完成签到 ,获得积分10
10秒前
liuguohua126完成签到,获得积分10
11秒前
波哥发布了新的文献求助10
11秒前
wuwu完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039